About Pficus De Med Private Limited
Data last updated:
Pficus De Med Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74900KA2016PTC085780. Its GSTIN is 29AAICP4809M1ZT (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Jitendra Kumar Jain (Managing Director) and Rikhabchand.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 9 And 10 R H B Colony Mahadevapura. R H B Colony Mahadevapura., Bangalore, Karnataka, India – 560048.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.01 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹61.05 Lakh (net margin 12.2%) and EBITDA of ₹86.64 Lakh (EBITDA margin 17.3%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 28% over five years.
The company has about 22 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Pficus. As per MCA filings, the company has open charges of ₹1.01 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pficus.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address9 And 10 R H B Colony Mahadevapura. R H B Colony Mahadevapura., Bangalore, Karnataka, India – 560048
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Pficus De Med Private Limited
The main business activity of Pficus De Med is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pficus De Med Private Limited FY 2024 filings available
Pficus De Med Private Limited reported revenue of ₹5.01 Cr (up 33% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Pficus De Med Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 28% over five years, including 33% growth in the latest year. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pficus De Med Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹86.64 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹61.05 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pficus De Med Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 12.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pficus De Med are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pficus De Med Private Limited
Pficus De Med Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Omnison Pharma Private Limited | ₹5.04 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Mission Happiness (Divine) Private Limited | ₹5.04 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Punjab, India |
| Lahiri Epharma India (OPC) Private Limited | ₹5.03 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Kolkata, West Bengal, India |
| Laxon Drugs Private Limited | ₹5.02 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Chandigarh, India |
| Hygeia Pharmaceuticals Mfg. Private Limited | ₹5.02 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Kolkata, West Bengal, India |
| Pficus De Med Private Limited this company | ₹5.01 Cr (FY 2024) | •••• | •••• | 33.0% | •••• | Bangalore, Karnataka, India |
| Accord Healthcare Limited | ₹5.01 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Ahmedabad, Gujarat, India |
| Pure Pharma Limited | ₹5.01 Cr (FY 2024) | •••• | •••• | 429.0% | •••• | Indore, Madhya Pradesh, India |
| Intracell Therapeutics Private Limited | ₹5 Cr (FY 2024) | •••• | •••• | 680.0% | •••• | Thane West, Maharashtra, India |
| Spark Medicare Private Limited. | ₹5 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | New Delhi, Delhi, India |
| Manibro Healthcare Private Limited | ₹5 Cr (FY 2024) | •••• | •••• | 34.0% | •••• | Cuttack, Orissa, India |
Peers are the five companies nearest above and the five nearest below Pficus De Med by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Pficus De Med Private Limited
Pficus De Med Private Limited is audited by B G K & Co LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B G K & Co LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Pficus De Med Private Limited
Pficus De Med has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jitendra Kumar Jain | Managing Director | 03 Feb 2016 | 10 Years 8 Months | Current |
| Rikhabchand Also directs: Mahaveer Transways LLP, Colour Pens Universal Private Limited | Director | 10 Mar 2016 | 10 Years 6 Months | Current |
| Sheetal Parekh Javerchand | Director | 03 Feb 2016 | 10 Years 8 Months | Current |
| Rameshkumar Jain | Director | 10 Mar 2016 | 10 Years 6 Months | Current |
Ownership and Shareholding of Pficus De Med Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pficus De Med Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Apr 2025 | Tata Capital Housing Finance Limited | ₹1.01 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Pficus De Med Private Limited
Pficus De Med Private Limited has a workforce of 22 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pficus De Med Private Limited
Pficus De Med Private Limited has 7 board changes on record since 2016: 4 appointments and 3 cessations. The latest: Rameshkumar Jain ceased to be Additional Director on 12 Sep 2016.
Credit Ratings, Litigation & Regulatory Alerts for Pficus De Med Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pficus De Med Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pficus De Med Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pficus De Med Private Limited
Pficus De Med has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAICP4809M1ZT | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pficus De Med Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pficus De Med Private Limited
Pficus De Med is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 February 2016 (10+ years old) and is registered under CIN U74900KA2016PTC085780.
Pficus De Med reported revenue of ₹5.01 Cr for FY 2024 (up 33% YoY).
Pficus De Med has 4 current directors:
- Jitendra Kumar Jain - Managing Director
- Rikhabchand - Director
- Sheetal Parekh Javerchand - Director
- Rameshkumar Jain - Director
Pficus De Med reported a net profit of ₹61.05 Lakh (net margin 12.2%) and EBITDA of ₹86.64 Lakh (EBITDA margin 17.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pficus De Med is 35% over three years and 28% over five years. In the latest year (FY 2024) revenue rose 33%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pficus De Med is 29AAICP4809M1ZT, registered in Karnataka.
The CIN (Corporate Identification Number) of Pficus De Med is U74900KA2016PTC085780. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pficus De Med was incorporated on 03 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Pficus De Med by revenue are Omnison Pharma Private Limited, Mission Happiness (Divine) Private Limited, Lahiri Epharma India (OPC) Private Limited, Laxon Drugs Private Limited, Hygeia Pharmaceuticals Mfg. Private Limited and 5 more, all in the Pharma industry (Formulations).
Rameshkumar Jain ceased to be Additional Director on 12 Sep 2016. Rikhabchand ceased to be Additional Director on 12 Sep 2016. Rameshkumar Jain was appointed as Director on 10 Mar 2016. Pficus De Med has 7 board changes on record in total.
Pficus De Med can be reached through the website pficus.in. Its registered office is in Bangalore, Karnataka, India.